The Limited Times

Now you can see non-English news...

Big Bang Santé du Figaro: prestigious speakers for the 2021 edition

2021-10-29T16:45:10.266Z


Research, old age, vaccination, on the menu for the 6th edition of this event which will be broadcast every morning from November 30 to December 2, live on Lefigaro.fr.


Is there anything more precious to humans than health

?

"

, Questioned Socrates.

The Covid-19 pandemic has placed

health

at the heart of the concerns of the French.

In October 2020, during its last Big Bang Health,

Le Figaro

plunged into this unprecedented crisis, with the ambition to provide reflections, analyzes and clarifications on an epidemic that has destabilized our societies to their very foundations. .

And now ?

Over time, new questions have arisen.

During three mornings

from November 30 to December 2

, punctuated by debates, reports, interviews, and through testimonies from

researchers, ministers, doctors, entrepreneurs

...

Le Figaro will

shed light on the upheavals in the world of health .

Big Bang of Scientific Research

Edith Heard

will open

the first part

of this Big Bang Health devoted to

scientific research

. The geneticist and director of the prestigious European Molecular Biology Laboratory (EMBL), at the origin of decisive discoveries in epigenetic sciences, will provide valuable insight and avenues for improving scientific research.

France's delay in developing a vaccine against Covid-19 has indeed highlighted the weakening of

research

and the deficiencies of our

health industries.

Many researchers have sounded the alarm for many years. Chronic insufficiency of investments, brain drain, crisis in the university system, time-consuming administrative tasks ... So many causes at the origin of this French disease.

Frédéric Collet

, president of Leem, the pharmaceutical industries union,

Rafaèle Tordjman

, PhD and founder of the health investment fund Jeito Capital as well as

Clarisse Angelier

, general delegate of the National Association for Research and Technology, will provide their answers during a debate on research.

Big Bang of old age

The second Big Bang addresses old

age

. In 2030, those over 65 will outnumber those under 15. This phenomenon raises questions. How to finance the care of the elderly and the loss of autonomy? Will governments finally succeed in adopting a “dependency law” that meets the challenges? What technological innovations will allow aging well at home? Health, well-being, financing ... how to meet the challenges of old age?

Luc Broussy

, president of the Silver economy sector, will discuss these issues alongside, among others,

Stéphane Junique

, president of the Vyv group.

During this morning,

Le Figaro will

present an immersive report at the Institute of Memory and Alzheimer's Disease, in Paris.

In conclusion of this Big Bang, the philosopher and novelist

Pascal Bruckner

, for whom,

“the brevity of our existence”

makes it

“its price and its flavor”

, enlightened us on the question: what is it to age well?

Vaccine big bang

The third morning will be dedicated to vaccination.

Stéphane Bancel

, CEO of Moderna, will take stock of the deployment of his vaccine - half a billion doses - developed in record time, one year after the first injections. How far will vaccination be required and what place will messenger RNA occupy? Experts will debate the place and future of the vaccine in healthcare, alongside

Alain Fischer

, the chairman of the steering committee for the vaccine strategy against Covid-19.

During these mornings,

Le Figaro will

offer

live

debates

,

reports

from all over France - Bordeaux, Nantes, Toulouse, Paris - and meetings with

innovative

French start-ups

to discover this

new world

of health full of promise. !

Follow us on social media: @BigBangFigaro 

Source: lefigaro

All business articles on 2021-10-29

You may like

Trends 24h

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.